Filings
Finds words inside filing documents. Searching STANDARD BIOTOOLS INC.'s filings · 48 documents indexed.
16 documents · 31 matches
-
LAB STANDARD BIOTOOLS INC. 10-K 2026-03-16
Item 1A. Risk Factors
tariff on product imports from almost all countries and individualized higher tariffs on certain other countries, including a 145% tariff15 matches in this document -
LAB STANDARD BIOTOOLS INC. 10-Q 2026-11-03
tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-08-05
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 10-Q 2026-08-05
tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition1 match in this document -
LAB STANDARD BIOTOOLS INC. 10-Q 2026-05-06
tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-05-05
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-02-24
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-01-30
Item 7.01. Regulation FD Disclosure.
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-01-30
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2026-01-08
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 10-Q 2025-11-04
tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2025-11-04
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 10-Q 2025-08-15
tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2025-08-11
impact on our continuing operations. It also assumes no expected effect from U.S. export controls and limited impact from tariffs.2 matches in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2025-06-23
Item 7.01. Regulation FD Disclosure.
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document -
LAB STANDARD BIOTOOLS INC. 8-K 2025-06-23
tariffs; challenges inherent in developing, manufacturing, launching, marketing, and selling new products; interruptions or delays in the supply of components1 match in this document
Page 1 of 1 · 16 documents